These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
482 related articles for article (PubMed ID: 18374506)
1. Stereotactic body radiotherapy for oligometastatic lung tumors. Norihisa Y; Nagata Y; Takayama K; Matsuo Y; Sakamoto T; Sakamoto M; Mizowaki T; Yano S; Hiraoka M Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):398-403. PubMed ID: 18374506 [TBL] [Abstract][Full Text] [Related]
2. Stereotactic Body Radiation Therapy (SBRT) for lung metastases. Okunieff P; Petersen AL; Philip A; Milano MT; Katz AW; Boros L; Schell MC Acta Oncol; 2006; 45(7):808-17. PubMed ID: 16982544 [TBL] [Abstract][Full Text] [Related]
3. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Wulf J; Haedinger U; Oppitz U; Thiele W; Mueller G; Flentje M Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):186-96. PubMed ID: 15337555 [TBL] [Abstract][Full Text] [Related]
4. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers. Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322 [TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer. Hiraoka M; Matsuo Y; Nagata Y Cancer Radiother; 2007; 11(1-2):32-5. PubMed ID: 17158081 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Nagata Y; Takayama K; Matsuo Y; Norihisa Y; Mizowaki T; Sakamoto T; Sakamoto M; Mitsumori M; Shibuya K; Araki N; Yano S; Hiraoka M Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1427-31. PubMed ID: 16169670 [TBL] [Abstract][Full Text] [Related]
7. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus. Song SY; Choi W; Shin SS; Lee SW; Ahn SD; Kim JH; Je HU; Park CI; Lee JS; Choi EK Lung Cancer; 2009 Oct; 66(1):89-93. PubMed ID: 19168260 [TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of stereotactic brain and/or body radiotherapy for patients with oligometastatic lesions. Inoue T; Katoh N; Aoyama H; Onimaru R; Taguchi H; Onodera S; Yamaguchi S; Shirato H Jpn J Clin Oncol; 2010 Aug; 40(8):788-94. PubMed ID: 20406944 [TBL] [Abstract][Full Text] [Related]
9. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region. Siddiqui F; Patel M; Khan M; McLean S; Dragovic J; Jin JY; Movsas B; Ryu S Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1047-53. PubMed ID: 19327895 [TBL] [Abstract][Full Text] [Related]
10. Local control of metastatic lung tumors treated with SBRT of 48 Gy in four fractions: in comparison with primary lung cancer. Hamamoto Y; Kataoka M; Yamashita M; Shinkai T; Kubo Y; Sugawara Y; Inoue T; Sakai S; Aono S; Takahashi T; Semba T; Uwatsu K Jpn J Clin Oncol; 2010 Feb; 40(2):125-9. PubMed ID: 19825814 [TBL] [Abstract][Full Text] [Related]
11. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. Rusthoven KE; Kavanagh BD; Burri SH; Chen C; Cardenes H; Chidel MA; Pugh TJ; Kane M; Gaspar LE; Schefter TE J Clin Oncol; 2009 Apr; 27(10):1579-84. PubMed ID: 19255320 [TBL] [Abstract][Full Text] [Related]
12. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. Baumann P; Nyman J; Hoyer M; Wennberg B; Gagliardi G; Lax I; Drugge N; Ekberg L; Friesland S; Johansson KA; Lund JA; Morhed E; Nilsson K; Levin N; Paludan M; Sederholm C; Traberg A; Wittgren L; Lewensohn R J Clin Oncol; 2009 Jul; 27(20):3290-6. PubMed ID: 19414667 [TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control. Videtic GM; Stephans K; Reddy C; Gajdos S; Kolar M; Clouser E; Djemil T Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):344-9. PubMed ID: 19765913 [TBL] [Abstract][Full Text] [Related]
14. Phase II study on stereotactic body radiotherapy of colorectal metastases. Hoyer M; Roed H; Traberg Hansen A; Ohlhuis L; Petersen J; Nellemann H; Kiil Berthelsen A; Grau C; Aage Engelholm S; Von der Maase H Acta Oncol; 2006; 45(7):823-30. PubMed ID: 16982546 [TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiation therapy using three fractions for isolated lung recurrence from colorectal cancer. Kim MS; Yoo SY; Cho CK; Yoo HJ; Choi CW; Seo YS; Kang JK; Lee DH; Hwang DY; Moon SM; Kim MS; Kang HJ; Kim YH Oncology; 2009; 76(3):212-9. PubMed ID: 19218825 [TBL] [Abstract][Full Text] [Related]